Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Weight

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
Urology|October 24, 2013
Men (aged 40-49 years) with a single baseline prostate-specific antigen below 1.0 ng/mL have a very low long-term risk of prostate cancer: results from a prospectively screened population cohortChristopher J Weight, Simon P Kim, Debra J Jacobson, et al.
European Urology Focus|November 10, 2019
Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_ScoreNiranjan J Sathianathen, Robert Lane, Benjamin Condon, et al.
European Urology Focus|February 25, 2019
Disparities in Bladder Cancer Treatment and Survival Amongst Elderly Patients with a Pre-existing Mental IllnessNiranjan J Sathianathen, Yunhua Fan, Stephanie L Jarosek, et al.
Chemical Research in Toxicology|November 3, 2018
Targeted and Untargeted Detection of DNA Adducts of Aromatic Amine Carcinogens in Human Bladder by Ultra-Performance Liquid Chromatography-High-Resolution Mass SpectrometryJingshu Guo, Peter W Villalta, Christopher J Weight, et al.
The Urologic Clinics of North America|March 22, 2023
Long-Term Renal Function Following Renal Cancer Surgery: Historical Perspectives, Current Status, and Future ConsiderationsAndrew M Wood, Tarik Benidir, Rebecca A Campbell, et al.
Urology|April 17, 2012
A prospective, controlled phase II study of neoadjuvant exisulind therapy before radical prostatectomy: effect on apoptosisChristopher J Weight, Simon P Kim, R Jeffrey Karnes, et al.
Journal of Imaging|June 25, 2025
A Study on Energy Consumption in AI-Driven Medical Image SegmentationR Prajwal, S J Pawan, Shahin Nazarian, et al.
Clinical Genitourinary Cancer|June 26, 2026
Trophoblastic-Differentiated Urothelial Carcinoma: Real-World Sequencing and Clinical ImplicationsGabriela M Diaz, Can Aydogdu, Sean McSweeney, et al.
Mayo Clinic Proceedings|December 3, 2013
Physical activity, quality of life, and burnout among physician trainees: the effect of a team-based, incentivized exercise programChristopher J Weight, Jacob L Sellon, Collette R Lessard-Anderson, et al.
Immunotargets and Therapy|December 20, 2017
The current status of immunobased therapies for metastatic renal-cell carcinomaNiranjan J Sathianathen, Suprita Krishna, J Kyle Anderson, et al.
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
Urology|October 24, 2013
Men (aged 40-49 years) with a single baseline prostate-specific antigen below 1.0 ng/mL have a very low long-term risk of prostate cancer: results from a prospectively screened population cohortChristopher J Weight, Simon P Kim, Debra J Jacobson, et al.
European Urology Focus|November 10, 2019
Early Online Attention Can Predict Citation Counts for Urological Publications: The #UroSoMe_ScoreNiranjan J Sathianathen, Robert Lane, Benjamin Condon, et al.
European Urology Focus|February 25, 2019
Disparities in Bladder Cancer Treatment and Survival Amongst Elderly Patients with a Pre-existing Mental IllnessNiranjan J Sathianathen, Yunhua Fan, Stephanie L Jarosek, et al.
Chemical Research in Toxicology|November 3, 2018
Targeted and Untargeted Detection of DNA Adducts of Aromatic Amine Carcinogens in Human Bladder by Ultra-Performance Liquid Chromatography-High-Resolution Mass SpectrometryJingshu Guo, Peter W Villalta, Christopher J Weight, et al.
The Urologic Clinics of North America|March 22, 2023
Long-Term Renal Function Following Renal Cancer Surgery: Historical Perspectives, Current Status, and Future ConsiderationsAndrew M Wood, Tarik Benidir, Rebecca A Campbell, et al.
Urology|April 17, 2012
A prospective, controlled phase II study of neoadjuvant exisulind therapy before radical prostatectomy: effect on apoptosisChristopher J Weight, Simon P Kim, R Jeffrey Karnes, et al.
Journal of Imaging|June 25, 2025
A Study on Energy Consumption in AI-Driven Medical Image SegmentationR Prajwal, S J Pawan, Shahin Nazarian, et al.
Clinical Genitourinary Cancer|June 26, 2026
Trophoblastic-Differentiated Urothelial Carcinoma: Real-World Sequencing and Clinical ImplicationsGabriela M Diaz, Can Aydogdu, Sean McSweeney, et al.
Mayo Clinic Proceedings|December 3, 2013
Physical activity, quality of life, and burnout among physician trainees: the effect of a team-based, incentivized exercise programChristopher J Weight, Jacob L Sellon, Collette R Lessard-Anderson, et al.
Immunotargets and Therapy|December 20, 2017
The current status of immunobased therapies for metastatic renal-cell carcinomaNiranjan J Sathianathen, Suprita Krishna, J Kyle Anderson, et al.
Pageof 18